摘要
目的研究白血病负荷与胸苷激酶(TK)/丙氧鸟苷(GCV)分离急性移植物抗宿主病(aGVHD)和移植物抗白血病效应(GVL)的关系。方法选择雄性C57BIJ6小鼠为供鼠,雌性F1小鼠为受鼠,进行H-2半相合CD三细胞和TK^+T细胞移植。将48只受鼠随机分为3个接种组,接种EL9611红白血病细胞(H-2^d)分别为10^5、10^6、10^7个。每组受鼠经。Co9.0Gy照射后,输入cD三细胞和TK^+T细胞分别为10^5、10^7;再随机分为对照组和GCV组。GCV组腹腔注射GCV50mg/(kg.d),连用7d,根据病理结果确定死因。结果第1、2接种组中的对照组均死于急性GVHD;GCV组30%~40%死于白血病,其余长期生存。GCV组生存时间较对照明组显延长(P〈0.05)。第3接种组均死于白血病,其对照组和GCV组生存时间无统计学差异。结论TK^+T细胞数量不变时,白血病负荷是影响TK/GCV分离急性GVHD和GVL效应的重要因素。
[ Objective] To explore the relationship between leukemia burden and function of thymidine kinase/gancielovir (TK/GCV) separating acute graft versus host disease (GVHD) and graft versus leukemia (GVL) effect. [ Methods ] Male C57BIJ6 mice acted as donors and female F1 mice acted as recipients. H-2 haplotyped matched CD34^+ cells and TK^+ T lymphocytes transplant was performed. 48 recipient mice were divided into three vaccination groups. 10^5, 10^6 and 10^7 EL9611 leukemic cells( H-2^d) were vaccinated . Recipient mice in cohorts 1-3 were inoculated 10^5, 10^6 and 10^7 EL9611 erythroblastic leukemia cells respectively. Every recipient mouse was irradiated by ^60Co at 9. 0 Gy ,infused 105 CD34^+ cells and 107 TK^+ T lymphocytes ,then divided into control group and GCV group in which GCV peritoneal injected was performed at 50 mg/( kg. d) for 7 d. Death cause was identified by pathological examinations. [ Results] Mice of control groups in the first ,second vaccination group were died of acute GVHD;30%-40% mice of GCV group were died of leukemia ,the rest had long term survival, live time in GCV group was obviously prolonged than control group( P 〈 0.05 ). The mice in the third vaccination group all died of leukemia ,there was no statistically difference of survivals between control group and GCV group(P 〉 0.05). [ Conclusion] At a fixed TK^+T lymphocyte number, the leukemia cell burden of transplanted mice is an important factor to influence the effect of TK/GCV separating acute GVHD and GVL.
出处
《山东医药》
CAS
北大核心
2007年第25期13-15,共3页
Shandong Medical Journal
关键词
胸苷激酶
H-2半相合
移植物抗宿主病
移植物抗白血病
thymidine klnase
H-2 haplotype matched
graft versus host disease
graft versus leukemia effect